Close
ACHEMA MIDDLE EAST 2026

Innovative Strategies For A Greener Pharmaceutical Sector

Climate change ranks among the most critical issues of our era, influencing every facet of life on Earth. Its effects on public health are...

Drug Discharge Seen In NYC As Consequences Of Heavy Rainfall

In the US, nearly 100 million individuals are prescribed medications like metoprolol and atenolol to lower their blood pressure. Unintentionally, some of these drugs...

Harnessing Wastewater For Disease Detection And Management

Wastewater management is increasingly recognized as a critical component in the surveillance and management of global health and diseases. With the interconnectedness of human,...

Liquid Biopsy in Cancer Diagnostics: Definition and Advantages

Consulting firm Fortune Business Insights reports that the global market of liquid biopsy, the procedure of collecting cancer-related materials from bodily fluids, was valued...

Current E&L Issues And How Parenteral Packaging Is Evolving

In mid-2018, nitrosamine content, also called NDMA, was found to go beyond the guidelines when it came to the daily intake limits of a...

Great Point Partners Acquires Lyocontract – A German CDMO

On a mission so as to debut the life sciences companies on an international stage, Great Point Partners, the healthcare investment firm, is making...

Transforming In 2024 & Beyond – Prefilled Syringes Market

Prefilled syringes have gone on to make up a decent portion in terms of injectable packaging segment in the past 10 years. As per...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...